601 POSTER Cross-trial analysis of immunological and clinical data resulting from phase I and II trials of MVA-5T4 (TroVax®) in colorectal, renal and prostate cancer patients

2008 ◽  
Vol 6 (12) ◽  
pp. 188
Author(s):  
R. Harrop ◽  
W.H. Shingler ◽  
N. Drury ◽  
M. Goonewardena ◽  
J. de Belin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Clinical Data ◽  
Trial Analysis ◽  
Phase I And Ii

Cross-trial Analysis of Immunologic and Clinical Data Resulting From Phase I and II Trials of MVA-5T4 (TroVax) in Colorectal, Renal, and Prostate Cancer Patients

2010 ◽  
Vol 33 (9) ◽  
pp. 999-1005 ◽  
Author(s):  
Richard Harrop ◽  
William Shingler ◽  
Michelle Kelleher ◽  
Jackie de Belin ◽  
Peter Treasure
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Clinical Data ◽  
Trial Analysis ◽  
Phase I And Ii

The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study

The Prostate ◽  
2011 ◽  
Vol 71 (13) ◽  
pp. 1455-1465 ◽  
Author(s):  
Jayaprakash Karkera ◽  
Hannes Steiner ◽  
Weimin Li ◽  
Viktor Skradski ◽  
Patrizia L. Moser ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Interleukin 6 ◽  
Phase I Study

scholarly journals Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data

2010 ◽  
Vol 1 (4) ◽  
pp. 635-639 ◽  
Author(s):  
YOSHIAKI YAMADA ◽  
KATSUYA NARUSE ◽  
KOGENTA NAKAMURA ◽  
TOMOHIRO TAKI ◽  
MOTOI TOBIUME ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Clinical Data
Sign in / Sign up

Export Citation Format

Share Document